Diseases
- The Voice of Science website - the Israel National Science Foundation
- No comments
- The Voice of Science website - the Israel National Science Foundation
- 2 תגובות
- Haifa University
- No comments
Dr. Tair Ben-Porat and Prof. Shira Zalbar-Sagi from the University of Haifa explain why the US debate on restricting the purchase of sugary drinks with food stamps reinforces a shift from personal to state responsibility—and what Israel can learn
- Weizmann Institute
A new study conducted in Israel and Ethiopia, led by researchers from the Weizmann Institute and Hadassah, reveals that the microbiome partially compensates for the damage that HIV causes to immune system cells in the intestinal mucosa and may lead to treatment directions.
BRCA genes not only protect against cancer but also regulate DNA repair pathways in a complex manner
- Avi Blizovsky
- One response
BRCA1 and BRCA2 are not “cancer genes,” but the guardians of the genome: New study maps checkpoints in DNA repair that may explain differences in risk and response to treatment
- The Technion
- One response
Researchers at the Technion have developed a biological implant with crystalline protection, which could completely change the treatment of diabetes and other chronic diseases.
- The Voice of Science website - the Israel National Science Foundation
- One response
Research led by Prof. Meital Gal-Tanaami of Bar-Ilan University and supported by the Israel Science Foundation is examining how a virus that remains in the cytoplasm manages to change genetic control in the nucleus, and is attempting to map points of intervention to reduce cancer risk as well.
- The Voice of Science website - the Israel National Science Foundation
- No comments
A study from Tel Aviv University identified two families of human antibodies that bind to the PSTS1 protein of the tuberculosis bacterium, and in a mouse experiment, the antibody treatment led to a 50% reduction in the bacterial load in the lungs.
- Avi Blizovsky
- No comments
New model generates a “map” of biomarkers from a standard staining image, improving prediction of disease course and response to immunotherapy in studies of thousands of patients
- Avi Blizovsky
- 2 תגובות
A new model in Science Advances combines lung cells, blood vessels, and immune cells from the same genetic origin, simulates breathing, and shows how early foci of cellular damage are formed during infection with the tuberculosis bacterium.
- Weizmann Institute
A new computational tool, SpotNeoMet, developed at the Weizmann Institute, detects resistance mutations that recur in many patients and create neoantigens – a possible target for “precision” immunotherapy for broad patient groups
- Tel Aviv University
- 2 תגובות
Researchers from Tel Aviv University have identified a link between loss of p53 activity (and sometimes deletions in the short arm of chromosome 17) and the adaptation of breast cancer cells to the brain environment through fatty acid pathways and communication with
- The Technion
- One response
Researchers at the Ruth and Baruch Rappaport Faculty of Medicine at the Technion present complex interrelationships between heart disease and cancer, in the hope that the findings will lead to improved treatment of both diseases.
- Avi Blizovsky
- No comments
Researchers at the University of Pennsylvania analyzed nearly a million immune cells from organ donors, identified a unique subpopulation of CD4 cells in the lymph nodes of the pancreas and changes in B cells in the spleen, and offer a direction for the development of a simple blood test.
- Tel Aviv University
- No comments
Along with developing models and software that could transform the study of lung cancer and genetic diseases, Tel Aviv University's IGEM team collaborated with the ORT Network and organized a synthetic biology competition for high school students with the participation of
- Dr.Roey Tsezana
Microsoft's Cell2Sentence-Scale Model Identifies Silmitasertib as a CK2 Inhibitor That Increases Antigen Presentation in "Cold" Cancer Cells – A New Insight Tested in the Lab and Demonstrates AI Research Creativity
- The Voice of Science website - the Israel National Science Foundation
- No comments
Prof. Ronit Sacchi-Painero identified two key proteins – CCL2 and P-Selectin – that are involved in cancer cell entry into the brain. Blocking either axis significantly reduced metastatic burden in mouse models and in vitro systems.
- Avi Blizovsky
- One response
Diabetes affects the brain through energy utilization, blood vessels, and inflammation—and sometimes the same medications work on both systems. Recent studies suggest a mutual connection:
- Avi Blizovsky
- One response
The new classification refers to diabetes that results from malnutrition in childhood.
- Tel Aviv University
A team led by Prof. Tal Dvir has succeeded in growing a customized spinal cord transplant from the patient's own cells. After success in animals, the Ministry of Health has approved the first human trial in Israel.
- Weizmann Institute
Research at the Weizmann Institute of Science demonstrates how communication between the brain and the body's organs plays a critical role in health and disease
- Avi Blizovsky
- No comments
Researchers have developed an innovative bandage that combines biologically active substances, which helps accelerate wound closure and prevent infections – with the potential to significantly improve the quality of life of those with diabetes.
- Avi Blizovsky
- 2 תגובות
Scientists have discovered that SDR42E1, a tiny gene linked to vitamin D absorption, could be the key to treating cancer: When it was turned off in cancer cells, the tumor stopped growing.
- The Technion
- 3 תגובות
Technion researchers have discovered that biological sex (or gender) affects the efficiency of digesting milk and its substitutes – a finding that may change perceptions of nutrition and food engineering.
- The Technion
- No comments
Joint development by Prof. Hussam Hayek from the Technion and researchers from Sun Yat-sen University enables glucose measurement and personalized metformin dosing using microneedles and nanobiological sensors
- Avi Blizovsky
- No comments
Scientists have managed to engineer compounds from the mold Aspergillus flavus that defeat leukemia cells – signaling hope for new drugs from nature
- Weizmann Institute
- No comments
Just days after their laboratories were damaged in an Iranian attack, Prof. Liran Shlush and Prof. Amos Tanai publish groundbreaking findings that are expected to advance the field of blood cell medicine.
- Avi Blizovsky
- 4 תגובות
A new injection, given twice a year, could revolutionize blood pressure treatment and prevent major cardiovascular events.
- Ben-Gurion University
- No comments
- Avi Blizovsky
- One response
A new 3D model for creating “virtual twins” of patients and populations – an automated tool for research and development of medical devices and treatments
- Avi Blizovsky
- No comments
Dassault Systèmes enters the next phase of the "Living Heart" project with AI-based virtual twinning * Matching and automation of virtual models of the heart, based on AI, will help simplify and accelerate
- Ben-Gurion University
- No comments
Comprehensive research by Ben-Gurion University and international partners indicates the importance of reducing intra-abdominal fat for improving metabolic health, even with moderate weight loss.
- Weizmann Institute
- Avi Blizovsky
- No comments
New study reveals that cancer risk may be determined before birth, suggesting new directions for diagnosis and treatment
- Avi Blizovsky
- One response
The lead researcher from the National Heart Disease Center in Osaka, notes: "In the future, if a rapid test is developed to identify harmful bacteria in the mouth and intestines, we could use this information to calculate stroke risk."
- The Hebrew University
Researchers from Tel Aviv University have developed an innovative platform based on nanoparticles, which enables the precise transport of two drugs at the same time to cancerous tumor sites, while improving treatment efficiency and reducing toxicity to healthy cells.
- Angle - a news agency for science and the environment
- Weizmann Institute
Weizmann Institute of Science scientists have discovered why the small hours of the night may be prone to disaster
- The Voice of Science website - the Israel National Science Foundation
- 6 תגובות
- Avi Blizovsky
- No comments
Researchers from the Hebrew University, the Weizmann Institute and the University of Tokyo have developed an innovative peptide that suppresses the activity of the MMP7 enzyme associated with cancer progression, with the potential for targeted therapies in aggressive cancers.
- The Hebrew University
- No comments
A method developed at the Hebrew University allows early detection of lung damage among cancer patients receiving antibody-based treatments, using a simple non-invasive blood test
- Avi Blizovsky
- One response
The Cancer Society: "The reason for using sweet flavors is an attempt to bring teenagers into the circle of users. Their sale must be banned immediately"
- Weizmann Institute
The institute's scientists revealed how aggressive breast cancer disrupts the immune response against it, and developed a treatment using an antibody that may be suitable for many types of cancer
- Avi Blizovsky
- One response
Prof. Carmit Levy: Immunotherapy has revolutionized cancer treatment," explains Prof. Carmi, "but about 50% of patients do not respond to the standard treatment - the PD-L1 protein. We found a new protein Ly6a against which treatment with an antibody
- Weizmann Institute
- Weizmann Institute
Copaxone may protect heart muscle cells and improve its function after a heart attack
- Weizmann Institute
In two recently published studies, Weizmann Institute of Science scientists mapped common brain cancer tumors with unprecedented resolution, and identified a possible reason why some patients do not respond to a new treatment
- Avi Blizovsky
- One response